Insider · CIK 0001808098
Johnson David Michael
Reports to the SEC for 2 companies · SAN DIEGO, CA
Transactions
50
Companies
2
Filings
10
CIK
0001808098
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-16 | ZNTLZentalis Pharmaceuticals, Inc.A Award | — |
| 2026-06-11 | AURAAura Biosciences, Inc.A Award | — |
| 2026-06-11 | AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-17 | AURAAura Biosciences, Inc.A Award | — |
| 2025-06-17 | AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-17 | ZNTLZentalis Pharmaceuticals, Inc.A Award | — |
| 2025-05-16 | AURAAura Biosciences, Inc.P Purchase | +$98K |
| 2025-05-16 | AURAAura Biosciences, Inc. · Common Stock Warrants (right to buy)P Purchase | — |
| 2024-06-21 | ZNTLZentalis Pharmaceuticals, Inc.A Award | — |
| 2024-06-20 | AURAAura Biosciences, Inc.A Award | — |
| 2024-06-20 | AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-11-10 | ZNTLZentalis Pharmaceuticals, Inc.P Purchase | +$168K |
| 2023-11-08 | AURAAura Biosciences, Inc.P Purchase | +$70.1K |
| 2023-11-08 | AURAAura Biosciences, Inc.P Purchase | +$73K |
| 2023-11-08 | AURAAura Biosciences, Inc.P Purchase | +$73K |
| 2023-11-07 | AURAAura Biosciences, Inc.P Purchase | +$545K |
| 2023-11-07 | AURAAura Biosciences, Inc.P Purchase | +$337K |
| 2023-11-07 | AURAAura Biosciences, Inc.P Purchase | +$337K |
| 2023-10-04 | AURAAura Biosciences, Inc.P Purchase | +$56.5K |
| 2023-10-03 | AURAAura Biosciences, Inc.P Purchase | +$112K |
| 2023-06-16 | ZNTLZentalis Pharmaceuticals, Inc.A Award | — |
| 2023-06-07 | AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-01-06 | AURAAura Biosciences, Inc.P Purchase | +$7,350 |
| 2023-01-06 | AURAAura Biosciences, Inc.P Purchase | +$9,501.04 |
| 2023-01-05 | AURAAura Biosciences, Inc.P Purchase | +$3,000 |
| 2023-01-05 | AURAAura Biosciences, Inc.P Purchase | +$960 |
| 2022-12-28 | AURAAura Biosciences, Inc.P Purchase | +$19.5K |
| 2022-12-28 | AURAAura Biosciences, Inc.P Purchase | +$19.5K |
| 2022-12-01 | AURAAura Biosciences, Inc.P Purchase | +$61.8K |
| 2022-12-01 | AURAAura Biosciences, Inc.P Purchase | +$61.8K |
| 2022-06-15 | AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-13 | AURAAura Biosciences, Inc.P Purchase | +$97.9K |
| 2022-06-13 | AURAAura Biosciences, Inc.P Purchase | +$97.9K |
| 2022-06-13 | AURAAura Biosciences, Inc.P Purchase | +$280K |
| 2022-06-10 | AURAAura Biosciences, Inc.P Purchase | +$45.1K |
| 2022-06-10 | AURAAura Biosciences, Inc.P Purchase | +$45.1K |
| 2022-06-10 | AURAAura Biosciences, Inc.P Purchase | +$150K |
| 2022-06-08 | ZNTLZentalis Pharmaceuticals, Inc.A Award | — |
| 2021-11-02 | AURAAura Biosciences, Inc.C Conversion | — |
| 2021-11-02 | AURAAura Biosciences, Inc. · Series E Convertible Preferred StockC Conversion | — |
| 2021-10-28 | AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-10-04 | ZNTLZentalis Pharmaceuticals, Inc.S Sale | −$323K |
| 2021-10-04 | ZNTLZentalis Pharmaceuticals, Inc.S Sale | −$526K |
| 2021-10-04 | ZNTLZentalis Pharmaceuticals, Inc.S Sale | −$6,720 |
| 2021-06-04 | ZNTLZentalis Pharmaceuticals, Inc.A Award | — |
| 2021-06-04 | ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-06-04 | ZNTLZentalis Pharmaceuticals, Inc.A Award | — |
| 2021-06-04 | ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-04-05 | ZNTLZentalis Pharmaceuticals, Inc.S Sale | −$561K |
| 2020-12-02 | ZNTLZentalis Pharmaceuticals, Inc.S Sale | −$79.7K |
Recent filings
- 4Johnson David Michael0001808098-26-000003SEC(opens sec.gov)
- 4Johnson David Michael0001193125-26-271168SEC(opens sec.gov)
- 4Johnson David Michael0000950170-25-087890SEC(opens sec.gov)
- 4Johnson David Michael0001725160-25-000133SEC(opens sec.gov)
- 4Johnson David Michael0000950170-25-075412SEC(opens sec.gov)
- 4Johnson David Michael0000950170-24-076707SEC(opens sec.gov)
- 4Johnson David Michael0001725160-24-000141SEC(opens sec.gov)
- 4Johnson David Michael0001725160-23-000201SEC(opens sec.gov)
- 4Johnson David Michael0000950170-23-062214SEC(opens sec.gov)
- 4Johnson David Michael0000950170-23-052244SEC(opens sec.gov)
Companies
Address
C/O ZENTALIS PHARMACEUTICALS, INC. 10275 SCIENCE CENTER DRIVE, SUITE 200
SAN DIEGO, CA, 92121